Your browser doesn't support javascript.
loading
The Ambulance Cardiac Chest Pain Evaluation in Scotland Study (ACCESS): A Prospective Cohort Study.
Cooper, Jamie G; Ferguson, James; Donaldson, Lorna A; Black, Kim M M; Livock, Kate J; Horrill, Judith L; Davidson, Elaine M; Scott, Neil W; Lee, Amanda J; Fujisawa, Takeshi; Lee, Kuan Ken; Anand, Atul; Shah, Anoop S V; Mills, Nicholas L.
Afiliação
  • Cooper JG; Emergency Department, Aberdeen Royal Infirmary, Aberdeen, United Kingdom; Department of Applied Medicine, University of Aberdeen, Aberdeen, United Kingdom. Electronic address: jamie.cooper2@nhs.scot.
  • Ferguson J; Emergency Department, Aberdeen Royal Infirmary, Aberdeen, United Kingdom; Department of Applied Medicine, University of Aberdeen, Aberdeen, United Kingdom.
  • Donaldson LA; Scottish Ambulance Service, Gyle Square, Edinburgh, United Kingdom.
  • Black KMM; Emergency Department, Aberdeen Royal Infirmary, Aberdeen, United Kingdom.
  • Livock KJ; Emergency Department, Aberdeen Royal Infirmary, Aberdeen, United Kingdom.
  • Horrill JL; Emergency Department, Aberdeen Royal Infirmary, Aberdeen, United Kingdom.
  • Davidson EM; Department of Clinical Biochemistry, Aberdeen Royal Infirmary, Aberdeen, United Kingdom.
  • Scott NW; Medical Statistics Team, University of Aberdeen, Aberdeen, United Kingdom.
  • Lee AJ; Medical Statistics Team, University of Aberdeen, Aberdeen, United Kingdom.
  • Fujisawa T; BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom; BHF Cardiovascular Biomarker Laboratory, University of Edinburgh, Edinburgh, United Kingdom.
  • Lee KK; BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.
  • Anand A; BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.
  • Shah ASV; BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom; Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.
  • Mills NL; BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom; BHF Cardiovascular Biomarker Laboratory, University of Edinburgh, Edinburgh, United Kingdom; Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.
Ann Emerg Med ; 77(6): 575-588, 2021 06.
Article em En | MEDLINE | ID: mdl-33926756
ABSTRACT
STUDY

OBJECTIVE:

To determine whether risk stratification in the out-of-hospital setting could identify patients with chest pain who are at low and high risk to avoid admission or aid direct transfer to cardiac centers.

METHODS:

Paramedics prospectively enrolled patients with suspected acute coronary syndrome without diagnostic ST-segment elevation on the ECG. The History, ECG, Age and Risk Factors (HEAR) score was recorded contemporaneously, and out-of-hospital samples were obtained to measure cardiac Troponin I (cTnI) level on a point-of-care device, to allow calculation of the History, ECG, Age, Risk Factors, and Troponin (HEART) score. HEAR and HEART scores less than or equal to 3 and greater than or equal to 7 were defined as low and high risk for major adverse cardiac events at 30 days.

RESULTS:

Of 1,054 patients (64 years [SD 15 years]; 42% women), 284 (27%) experienced a major adverse cardiac event at 30 days. The HEAR score was calculated in all patients, with point-of-care cTnI testing available in 357 (34%). A HEAR score less than or equal to 3 identified 32% of patients (334/1,054) as low risk, with a sensitivity of 84.9% (95% confidence interval [CI] 80.7% to 89%), whereas a score greater than or equal to 7 identified just 3% of patients (30/1,054) as high risk, with a specificity of 98.7% (95% CI 97.9% to 99.5%). A point-of-care HEART score less than or equal to 3 identified a similar proportion as low risk (30%), with a sensitivity of 87.0% (95% CI 80.7% to 93.4%), whereas a score greater than or equal to 7 identified 14% as high risk, with a specificity of 94.8% (95% CI 92.0% to 97.5%).

CONCLUSION:

Paramedics can use the HEAR score to discriminate risk, but even when used in combination with out-of-hospital point-of-care cTnI testing, the HEART score does not safely rule out major adverse cardiac events, and only a small proportion of patients are identified as high risk.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Admissão do Paciente / Dor no Peito / Ambulâncias / Transferência de Pacientes / Medição de Risco Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Admissão do Paciente / Dor no Peito / Ambulâncias / Transferência de Pacientes / Medição de Risco Idioma: En Ano de publicação: 2021 Tipo de documento: Article